Press Releases

June 22, 2026
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise
Read more
June 22, 2026
Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise

Initiative creates new resource to support and accelerate early-stage therapeutics companies; Company forms inaugural partnership with Durham-based Cape Fear BioCapital to connect incubator to a seed-stage venture partner
Read More
June 11, 2026
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
Presentations, panels and moderated discussions across the four-day conference will span proven AI applications across the clinical trial lifecycle, real world evidence, risk-based quality management and patient-centered research
Read More
June 10, 2026
Parexel to Showcase Seven Research Posters and Debut New Hematology Playbook at the European Hematology Association Congress 2026
Parexel presents new hematology research at EHA; launches "At the Turning Point: Shaping the Future of Hematology" playbook
Read More
May 28, 2026
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026
Parexel presents new oncology research and patient-focused creative campaign; reinforces its patient-first clinical development leadership position.
Read More
May 18, 2026
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development

Innovative, proprietary suite of artificial intelligence services and capabilities deliver proven speed, quality and efficiency results for sponsors and patients
Read More
April 29, 2026
Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana
AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
Read More
April 29, 2026
Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle

Initial performance data demonstrates 60%+ acceleration in NDA authoring timelines. SAN FRANCISCO & RALEIGH, N.C.--( BUSINESS WIRE)--Weave Bio, the leader in AI-native regulatory automation for drug development, and strategic partner Parexel, a leading global clinical development partner, today
Read More
April 28, 2026
Parexel Statement on U.S. Food and Drug Administration Announcement “FDA Announces Major Steps to Implement Real-Time Clinical Trials: Agency unveils real-time trial proofs-of-concept and upcoming pilot program”

Parexel provided a statement supporting the U.S. Food and Drug Administration (FDA) announcement around Real-Time Clinical Trials (RTCT).
Read More